Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023

SELL
$2.06 - $3.47 $1,030 - $1,735
-500 Reduced 4.46%
10,709 $23,000
Q3 2022

Nov 01, 2022

SELL
$2.6 - $5.12 $17,992 - $35,430
-6,920 Reduced 38.17%
11,209 $32 Million
Q2 2022

Aug 12, 2022

SELL
$2.19 - $3.98 $9,708 - $17,643
-4,433 Reduced 19.65%
18,129 $45,000
Q1 2022

Apr 26, 2022

BUY
$3.28 - $7.12 $7,612 - $16,525
2,321 Added 11.47%
22,562 $86,000
Q4 2021

Jan 20, 2022

BUY
$6.55 - $13.25 $37,400 - $75,657
5,710 Added 39.3%
20,241 $134,000
Q3 2021

Oct 19, 2021

BUY
$7.29 - $11.0 $105,930 - $159,841
14,531 New
14,531 $131,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $657M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.